June 19 (Reuters) - Acasti Pharma Inc ACST.V :
* ACASTI PHARMA RECEIVES FDA RESPONSE TO TRILOGY 1 BRIEFING PACKAGE
* ACASTI PHARMA INC - FDA HAS PROVIDED ACASTI WITH A WRITTEN RESPONSE TO ITS TYPE C MEETING REQUEST AND BRIEFING PACKAGE
* ACASTI PHARMA - FDA CONFIRMED THAT IT WILL REQUIRE PIVOTAL EFFICACY ANALYSES FOR TRILOGY 2 TO BE PERFORMED ON FULL INTENT TO TREAT POPULATION